טוען...
Lead-Time Models Should Not Be Used to Estimate Overdiagnosis in Cancer Screening
Lead-time can mean two different things: Clinical lead-time is the lead-time for clinically relevant tumors; that is, those that are not overdiagnosed. Model-based lead-time is a theoretical construct where the time when the tumor would have caused symptoms is not limited by the person’s death. It i...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4139512/ https://ncbi.nlm.nih.gov/pubmed/24590736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-014-2812-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|